TNNI3 and diabetes mellitus: By combining these tools into a stepwise algorithm, clinicians can move frombroad population-based screening (SCORE2-Diabetes and FIB-4) to targeted advancedtesting (GLS and hs-cTnI) in selected high-risk patients.